Truist Financial Has Lowered Expectations for Markel Group (NYSE:MKL) Stock Price

Markel Group (NYSE:MKLGet Free Report) had its price target decreased by equities research analysts at Truist Financial from $2,100.00 to $1,950.00 in a research note issued on Thursday, Marketbeat Ratings reports. The firm currently has a “hold” rating on the insurance provider’s stock. Truist Financial’s price objective would suggest a potential upside of 9.45% from the company’s previous close.

Other research analysts have also recently issued reports about the stock. Brean Capital began coverage on shares of Markel Group in a research report on Tuesday, March 24th. They set a “neutral” rating and a $2,100.00 price target on the stock. Zacks Research lowered shares of Markel Group from a “strong-buy” rating to a “hold” rating in a report on Monday, January 19th. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Markel Group in a research note on Friday, March 27th. Finally, Wall Street Zen raised shares of Markel Group from a “hold” rating to a “buy” rating in a report on Saturday, March 14th. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Markel Group presently has a consensus rating of “Hold” and a consensus price target of $2,025.00.

Read Our Latest Analysis on MKL

Markel Group Trading Up 0.5%

Shares of MKL stock opened at $1,781.71 on Thursday. The business has a 50-day moving average price of $1,948.66 and a two-hundred day moving average price of $2,018.57. Markel Group has a 12-month low of $1,719.41 and a 12-month high of $2,207.59. The company has a quick ratio of 0.63, a current ratio of 0.63 and a debt-to-equity ratio of 0.24. The firm has a market cap of $22.29 billion, a P/E ratio of 12.84 and a beta of 0.67.

Markel Group (NYSE:MKLGet Free Report) last announced its quarterly earnings data on Tuesday, April 28th. The insurance provider reported ($18.90) EPS for the quarter, missing the consensus estimate of $26.38 by ($45.28). The firm had revenue of $2.82 billion for the quarter, compared to the consensus estimate of $3.66 billion. Markel Group had a net margin of 10.85% and a return on equity of 7.90%. Equities analysts anticipate that Markel Group will post 117.52 EPS for the current fiscal year.

Insider Buying and Selling

In other Markel Group news, CEO Simon Wilson sold 100 shares of the company’s stock in a transaction that occurred on Thursday, February 26th. The stock was sold at an average price of $2,079.48, for a total transaction of $207,948.00. Following the completion of the transaction, the chief executive officer owned 2,397 shares of the company’s stock, valued at $4,984,513.56. This represents a 4.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 1.08% of the stock is owned by insiders.

Hedge Funds Weigh In On Markel Group

Hedge funds have recently made changes to their positions in the business. Brighton Jones LLC purchased a new position in Markel Group during the 4th quarter valued at $236,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Markel Group by 13.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 109 shares of the insurance provider’s stock worth $204,000 after purchasing an additional 13 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Markel Group by 9.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 34,704 shares of the insurance provider’s stock worth $64,883,000 after purchasing an additional 3,083 shares during the period. Empowered Funds LLC boosted its stake in shares of Markel Group by 49.1% during the 1st quarter. Empowered Funds LLC now owns 416 shares of the insurance provider’s stock valued at $778,000 after purchasing an additional 137 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership bought a new stake in shares of Markel Group during the 2nd quarter valued at about $463,000. 77.12% of the stock is owned by hedge funds and other institutional investors.

Markel Group Company Profile

(Get Free Report)

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.

Featured Stories

Analyst Recommendations for Markel Group (NYSE:MKL)

Receive News & Ratings for Markel Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel Group and related companies with MarketBeat.com's FREE daily email newsletter.